Ionis Pharmaceuticals, Inc. (IONS)
USD 32.78
(3.37%)
USD 32.78
(3.37%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.45 Billion USD | 8.07% |
| 2022 | 1.34 Billion USD | 15.85% |
| 2021 | 1.16 Billion USD | 55.01% |
| 2020 | 749 Million USD | 5.49% |
| 2019 | 710 Million USD | 24.95% |
| 2018 | 568.21 Million USD | 6.58% |
| 2017 | 533.11 Million USD | 6.49% |
| 2016 | 500.63 Million USD | 25.92% |
| 2015 | 397.57 Million USD | 5.88% |
| 2014 | 375.5 Million USD | 149.78% |
| 2013 | 150.33 Million USD | 4.41% |
| 2012 | 143.99 Million USD | -34.2% |
| 2011 | 218.84 Million USD | 41.73% |
| 2010 | 154.4 Million USD | 1245.24% |
| 2009 | 11.47 Million USD | -93.42% |
| 2008 | 174.5 Million USD | 2.59% |
| 2007 | 170.1 Million USD | 21.21% |
| 2006 | 140.33 Million USD | -5.02% |
| 2005 | 147.75 Million USD | -40.22% |
| 2004 | 247.15 Million USD | 7.52% |
| 2003 | 229.87 Million USD | 0.52% |
| 2002 | 228.69 Million USD | 68.72% |
| 2001 | 135.54 Million USD | 26.84% |
| 2000 | 106.86 Million USD | 17.17% |
| 1999 | 91.2 Million USD | 12.18% |
| 1998 | 81.3 Million USD | 38.27% |
| 1997 | 58.8 Million USD | 125.29% |
| 1996 | 26.1 Million USD | 169.07% |
| 1995 | 9.7 Million USD | -17.09% |
| 1994 | 11.7 Million USD | -14.6% |
| 1993 | 13.7 Million USD | 7.03% |
| 1992 | 12.8 Million USD | 113.33% |
| 1991 | 6 Million USD | 400.0% |
| 1990 | 1.2 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 1.97 Billion USD | 0.4% |
| 2024 Q1 | 1.96 Billion USD | 35.47% |
| 2023 Q3 | 1.4 Billion USD | -4.75% |
| 2023 Q2 | 1.47 Billion USD | 8.3% |
| 2023 Q1 | 1.36 Billion USD | 1.19% |
| 2023 FY | 1.45 Billion USD | 8.07% |
| 2023 Q4 | 1.45 Billion USD | 3.53% |
| 2022 Q4 | 1.34 Billion USD | 9.85% |
| 2022 Q3 | 1.22 Billion USD | 0.09% |
| 2022 Q1 | 1.22 Billion USD | 5.27% |
| 2022 FY | 1.34 Billion USD | 15.85% |
| 2022 Q2 | 1.22 Billion USD | 0.09% |
| 2021 FY | 1.16 Billion USD | 55.01% |
| 2021 Q2 | 1.28 Billion USD | 40.75% |
| 2021 Q1 | 909.78 Million USD | 21.47% |
| 2021 Q4 | 1.16 Billion USD | -9.44% |
| 2021 Q3 | 1.28 Billion USD | 0.12% |
| 2020 FY | 749 Million USD | 5.49% |
| 2020 Q4 | 749 Million USD | -6.25% |
| 2020 Q2 | 789.18 Million USD | 1.23% |
| 2020 Q1 | 779.59 Million USD | 9.8% |
| 2020 Q3 | 798.93 Million USD | 1.24% |
| 2019 Q4 | 710 Million USD | 8.19% |
| 2019 Q1 | 637.27 Million USD | 12.15% |
| 2019 Q2 | 587 Million USD | -7.89% |
| 2019 FY | 710 Million USD | 24.95% |
| 2019 Q3 | 656.25 Million USD | 11.8% |
| 2018 Q4 | 568.21 Million USD | -8.21% |
| 2018 Q3 | 619 Million USD | 1.45% |
| 2018 Q1 | 541.63 Million USD | 1.6% |
| 2018 FY | 568.21 Million USD | 6.58% |
| 2018 Q2 | 610.13 Million USD | 12.65% |
| 2017 Q4 | 533.11 Million USD | -8.79% |
| 2017 Q1 | 580.8 Million USD | 16.01% |
| 2017 FY | 533.11 Million USD | 6.49% |
| 2017 Q3 | 584.49 Million USD | 13.16% |
| 2017 Q2 | 516.53 Million USD | -11.07% |
| 2016 FY | 500.63 Million USD | 25.92% |
| 2016 Q1 | 395.45 Million USD | -0.53% |
| 2016 Q2 | 473.95 Million USD | 19.85% |
| 2016 Q3 | 480.33 Million USD | 1.34% |
| 2016 Q4 | 500.63 Million USD | 4.23% |
| 2015 Q3 | 463.98 Million USD | 20.1% |
| 2015 Q1 | 452.7 Million USD | 20.56% |
| 2015 Q4 | 397.57 Million USD | -14.31% |
| 2015 Q2 | 386.31 Million USD | -14.66% |
| 2015 FY | 397.57 Million USD | 5.88% |
| 2014 Q3 | 227.05 Million USD | 0.82% |
| 2014 Q4 | 375.5 Million USD | 65.38% |
| 2014 FY | 375.5 Million USD | 149.78% |
| 2014 Q2 | 225.2 Million USD | 0.81% |
| 2014 Q1 | 223.4 Million USD | 48.6% |
| 2013 Q3 | 219.8 Million USD | 0.82% |
| 2013 Q4 | 150.33 Million USD | -31.6% |
| 2013 Q1 | 216.26 Million USD | 50.19% |
| 2013 FY | 150.33 Million USD | 4.41% |
| 2013 Q2 | 218 Million USD | 0.81% |
| 2012 Q3 | 226.46 Million USD | -1.99% |
| 2012 FY | 143.99 Million USD | -34.2% |
| 2012 Q4 | 143.99 Million USD | -36.42% |
| 2012 Q1 | 220.3 Million USD | 0.67% |
| 2012 Q2 | 231.05 Million USD | 4.88% |
| 2011 Q3 | 212.85 Million USD | 5.76% |
| 2011 Q2 | 201.26 Million USD | 29.68% |
| 2011 Q1 | 155.19 Million USD | 0.51% |
| 2011 FY | 218.84 Million USD | 41.73% |
| 2011 Q4 | 218.84 Million USD | 2.81% |
| 2010 Q1 | 141.6 Million USD | 799.21% |
| 2010 FY | 154.4 Million USD | 1245.24% |
| 2010 Q4 | 154.4 Million USD | 6.24% |
| 2010 Q2 | 149.65 Million USD | 5.68% |
| 2010 Q3 | 145.33 Million USD | -2.89% |
| 2009 FY | 11.47 Million USD | -93.42% |
| 2009 Q2 | 135.1 Million USD | 0.85% |
| 2009 Q3 | 12.53 Million USD | -90.72% |
| 2009 Q4 | 15.74 Million USD | 25.66% |
| 2009 Q1 | 133.95 Million USD | -23.23% |
| 2008 Q1 | 168.36 Million USD | -1.02% |
| 2008 Q4 | 174.5 Million USD | 3.88% |
| 2008 Q3 | 167.97 Million USD | -2.1% |
| 2008 Q2 | 171.58 Million USD | 1.91% |
| 2008 FY | 174.5 Million USD | 2.59% |
| 2007 FY | 170.1 Million USD | 21.21% |
| 2007 Q1 | 256.69 Million USD | 82.92% |
| 2007 Q2 | 174.02 Million USD | -32.21% |
| 2007 Q3 | 172.17 Million USD | -1.06% |
| 2007 Q4 | 170.1 Million USD | -1.21% |
| 2006 Q2 | 143.91 Million USD | -1.3% |
| 2006 FY | 140.33 Million USD | -5.02% |
| 2006 Q4 | 140.33 Million USD | -1.46% |
| 2006 Q3 | 142.42 Million USD | -1.04% |
| 2006 Q1 | 145.8 Million USD | -1.32% |
| 2005 Q1 | 253.03 Million USD | 2.38% |
| 2005 Q3 | 150.15 Million USD | -40.77% |
| 2005 Q4 | 147.75 Million USD | -1.6% |
| 2005 Q2 | 253.53 Million USD | 0.2% |
| 2005 FY | 147.75 Million USD | -40.22% |
| 2004 Q3 | 239.39 Million USD | 2.18% |
| 2004 Q4 | 247.15 Million USD | 3.24% |
| 2004 Q1 | 229.91 Million USD | 0.02% |
| 2004 FY | 247.15 Million USD | 7.52% |
| 2004 Q2 | 234.29 Million USD | 1.91% |
| 2003 Q4 | 229.87 Million USD | -0.99% |
| 2003 FY | 229.87 Million USD | 0.52% |
| 2003 Q3 | 232.17 Million USD | 10.27% |
| 2003 Q2 | 210.55 Million USD | -4.53% |
| 2003 Q1 | 220.55 Million USD | -3.56% |
| 2002 Q2 | 201.39 Million USD | 40.38% |
| 2002 Q4 | 228.69 Million USD | 20.81% |
| 2002 FY | 228.69 Million USD | 68.72% |
| 2002 Q1 | 143.46 Million USD | 5.84% |
| 2002 Q3 | 189.3 Million USD | -6.0% |
| 2001 Q4 | 135.54 Million USD | -10.32% |
| 2001 FY | 135.54 Million USD | 26.84% |
| 2001 Q3 | 151.14 Million USD | 17.68% |
| 2001 Q2 | 128.43 Million USD | 17.98% |
| 2001 Q1 | 108.85 Million USD | 1.87% |
| 2000 Q1 | 95.06 Million USD | 4.24% |
| 2000 FY | 106.86 Million USD | 17.17% |
| 2000 Q2 | 98.22 Million USD | 3.33% |
| 2000 Q3 | 99.86 Million USD | 1.67% |
| 2000 Q4 | 106.86 Million USD | 7.0% |
| 1999 Q3 | 89.8 Million USD | 4.54% |
| 1999 Q2 | 85.9 Million USD | 4.12% |
| 1999 Q4 | 91.2 Million USD | 1.56% |
| 1999 Q1 | 82.5 Million USD | 1.48% |
| 1999 FY | 91.2 Million USD | 12.18% |
| 1998 Q1 | 58.9 Million USD | 0.17% |
| 1998 Q4 | 81.3 Million USD | 6.83% |
| 1998 Q3 | 76.1 Million USD | 2.7% |
| 1998 FY | 81.3 Million USD | 38.27% |
| 1998 Q2 | 74.1 Million USD | 25.81% |
| 1997 Q1 | 25.8 Million USD | -1.15% |
| 1997 Q3 | 35.6 Million USD | 1.42% |
| 1997 FY | 58.8 Million USD | 125.29% |
| 1997 Q4 | 58.8 Million USD | 65.17% |
| 1997 Q2 | 35.1 Million USD | 36.05% |
| 1996 Q3 | 10.1 Million USD | 2.02% |
| 1996 Q2 | 9.9 Million USD | -4.81% |
| 1996 FY | 26.1 Million USD | 169.07% |
| 1996 Q1 | 10.4 Million USD | 7.22% |
| 1996 Q4 | 26.1 Million USD | 158.42% |
| 1995 Q4 | 9.7 Million USD | -2.02% |
| 1995 Q2 | 10.4 Million USD | -5.45% |
| 1995 Q3 | 9.9 Million USD | -4.81% |
| 1995 Q1 | 11 Million USD | -5.98% |
| 1995 FY | 9.7 Million USD | -17.09% |
| 1994 Q1 | 12.9 Million USD | -5.84% |
| 1994 FY | 11.7 Million USD | -14.6% |
| 1994 Q4 | 11.7 Million USD | -4.1% |
| 1994 Q2 | 12.1 Million USD | -6.2% |
| 1994 Q3 | 12.2 Million USD | 0.83% |
| 1993 Q2 | 9.7 Million USD | 8.99% |
| 1993 FY | 13.7 Million USD | 7.03% |
| 1993 Q3 | 11.1 Million USD | 14.43% |
| 1993 Q4 | 13.7 Million USD | 23.42% |
| 1993 Q1 | 8.9 Million USD | -30.47% |
| 1992 Q2 | 12.2 Million USD | 14.02% |
| 1992 FY | 12.8 Million USD | 113.33% |
| 1992 Q1 | 10.7 Million USD | 78.33% |
| 1992 Q3 | 13.2 Million USD | 8.2% |
| 1992 Q4 | 12.8 Million USD | -3.03% |
| 1991 FY | 6 Million USD | 400.0% |
| 1991 Q3 | 6.5 Million USD | 6.56% |
| 1991 Q4 | 6 Million USD | -7.69% |
| 1991 Q1 | 1.4 Million USD | 16.67% |
| 1991 Q2 | 6.1 Million USD | 335.71% |
| 1990 Q4 | 1.2 Million USD | 0.0% |
| 1990 FY | 1.2 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| NeuroSense Therapeutics Ltd. | 142 Thousand USD | -1023519.014% |
| Psyence Biomedical Ltd. | 7.65 Million USD | -18882.155% |
| XOMA Corporation | 124.45 Million USD | -1067.97% |
| Mesoblast Limited | 118.92 Million USD | -1122.252% |
| Xeris Biopharma Holdings, Inc. | 229.19 Million USD | -534.204% |
| Aptorum Group Limited | 3.36 Million USD | -43129.25% |
| Qualigen Therapeutics, Inc. | 1.29 Million USD | -111778.163% |
| HilleVax, Inc. | 51.19 Million USD | -2739.332% |
| Rocket Pharmaceuticals, Inc. | 25.04 Million USD | -5704.405% |
| Corbus Pharmaceuticals Holdings, Inc. | 20.88 Million USD | -6859.983% |
| Precision BioSciences, Inc. | 31.26 Million USD | -4548.647% |
| Dyadic International, Inc. | 136.92 Thousand USD | -1061427.507% |
| Intensity Therapeutics, Inc. | 158 Thousand USD | -919861.392% |
| IDEAYA Biosciences, Inc. | 2.87 Million USD | -50510.689% |
| Eton Pharmaceuticals, Inc. | 5.45 Million USD | -26545.995% |
| VYNE Therapeutics Inc. | 214 Thousand USD | -679123.832% |
| EyePoint Pharmaceuticals, Inc. | 5.46 Million USD | -26477.784% |
| Adaptive Biotechnologies Corporation | 229.43 Million USD | -533.538% |
| Tenaya Therapeutics, Inc. | 12.42 Million USD | -11599.445% |
| IGM Biosciences, Inc. | 40.5 Million USD | -3488.454% |
| Opthea Limited | 200.62 Million USD | -624.492% |
| Milestone Pharmaceuticals Inc. | 51.77 Million USD | -2707.415% |
| Abeona Therapeutics Inc. | 5.4 Million USD | -26817.389% |
| Tonix Pharmaceuticals Holding Corp. | 9.81 Million USD | -14712.382% |
| Ligand Pharmaceuticals Incorporated | 6.16 Million USD | -23477.275% |
| NextCure, Inc. | 6.6 Million USD | -21906.646% |
| Inhibikase Therapeutics, Inc. | 622 Thousand USD | -233586.815% |
| Ovid Therapeutics Inc. | 46 Million USD | -3059.749% |
| CASI Pharmaceuticals, Inc. | 21.23 Million USD | -6743.726% |
| Arcturus Therapeutics Holdings Inc. | 30.21 Million USD | -4710.494% |
| Syros Pharmaceuticals, Inc. | 62.07 Million USD | -2241.585% |
| Senti Biosciences, Inc. | 37.66 Million USD | -3759.021% |
| Apollomics, Inc. | 4.66 Million USD | -31085.132% |
| PureTech Health plc | 25.51 Million USD | -5597.472% |
| Oncternal Therapeutics, Inc. | 318 Thousand USD | -456987.736% |
| Barinthus Biotherapeutics plc | 12.97 Million USD | -11101.75% |
| Kymera Therapeutics, Inc. | 84.67 Million USD | -1616.63% |
| ChromaDex Corporation | 3.27 Million USD | -44255.783% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Akebia Therapeutics, Inc. | 104.18 Million USD | -1295.192% |
| Sangamo Therapeutics, Inc. | 38.1 Million USD | -3714.663% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | 104.77 Million USD | -1287.296% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Fate Therapeutics, Inc. | 103.53 Million USD | -1303.897% |
| BioXcel Therapeutics, Inc. | 101.38 Million USD | -1333.697% |
| Fortress Biotech, Inc. | 88.59 Million USD | -1540.711% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| Lyell Immunopharma, Inc. | 63.16 Million USD | -2201.105% |
| Celcuity Inc. | 37.44 Million USD | -3781.664% |
| ContextLogic Inc. | 6 Million USD | -24125.65% |
| GH Research PLC | 343 Thousand USD | -423672.303% |
| HOOKIPA Pharma Inc. | 6.55 Million USD | -22060.985% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -3928383.784% |
| ImmuCell Corporation | 11.96 Million USD | -12043.89% |
| Amarin Corporation plc | 8.73 Million USD | -16536.592% |
| TG Therapeutics, Inc. | 110.79 Million USD | -1211.918% |
| X4 Pharmaceuticals, Inc. | 58.28 Million USD | -2394.019% |
| Acelyrin, Inc. | 1.19 Million USD | -121636.935% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Seer, Inc. | 28.25 Million USD | -5043.632% |
| Novavax, Inc. | 280.63 Million USD | -417.946% |
| Phathom Pharmaceuticals, Inc. | 139.03 Million USD | -945.486% |
| Jazz Pharmaceuticals plc | 5.79 Billion USD | 74.925% |
| AnaptysBio, Inc. | 17.81 Million USD | -8059.532% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -26832.351% |
| PMV Pharmaceuticals, Inc. | 13.28 Million USD | -10840.381% |
| AbCellera Biologics Inc. | 77.38 Million USD | -1778.443% |
| CorMedix Inc. | 667.63 Thousand USD | -217615.598% |
| Cartesian Therapeutics, Inc. | 10.95 Million USD | -13168.27% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 46.223% |
| Aptose Biosciences Inc. | 1 Million USD | -143842.401% |
| ZyVersa Therapeutics, Inc. | 8656.00 USD | -16792171.257% |
| Soligenix, Inc. | 3.49 Million USD | -41494.323% |
| Century Therapeutics, Inc. | 48.17 Million USD | -2917.457% |
| Arrowhead Pharmaceuticals, Inc. | 115.17 Million USD | -1162.07% |
| TransCode Therapeutics, Inc. | 450.57 Thousand USD | -322499.324% |
| Kura Oncology, Inc. | 17.2 Million USD | -8350.808% |
| RAPT Therapeutics, Inc. | 6.9 Million USD | -20947.48% |
| Ardelyx, Inc. | 55.98 Million USD | -2496.44% |
| Ainos, Inc. | 5.96 Million USD | -24273.696% |
| TScan Therapeutics, Inc. | 92.43 Million USD | -1472.533% |
| Ocean Biomedical, Inc. | 2.15 Million USD | -67506.465% |
| Prothena Corporation plc | 11.83 Million USD | -12181.698% |
| CytomX Therapeutics, Inc. | 13.97 Million USD | -10301.739% |
| Autolus Therapeutics plc | 52.96 Million USD | -2644.235% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Adaptimmune Therapeutics plc | 25.23 Million USD | -5660.012% |
| Eterna Therapeutics Inc. | 41.84 Million USD | -3373.793% |
| Celularity Inc. | 65.41 Million USD | -2121.959% |
| Rallybio Corporation | 392 Thousand USD | -370700.765% |
| GRI Bio, Inc. | 14 Thousand USD | -10382321.429% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Omeros Corporation | 338.28 Million USD | -329.684% |
| INmune Bio, Inc. | 10.43 Million USD | -13826.789% |
| Heron Therapeutics, Inc. | 179.62 Million USD | -709.194% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -24506.814% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -1779453.134% |
| Entero Therapeutics, Inc. | 826.84 Thousand USD | -175693.62% |
| Humacyte, Inc. | 58.1 Million USD | -2401.53% |
| Atara Biotherapeutics, Inc. | 57.87 Million USD | -2411.645% |
| Coherus BioSciences, Inc. | 480.84 Million USD | -202.29% |
| Immunocore Holdings plc | 84.03 Million USD | -1629.745% |
| Cocrystal Pharma, Inc. | 1.85 Million USD | -78342.472% |
| Verastem, Inc. | 41.55 Million USD | -3397.7% |
| Pliant Therapeutics, Inc. | 11.37 Million USD | -12681.736% |
| Histogen Inc. | 4.62 Million USD | -31348.269% |
| Surrozen, Inc. | 3.37 Million USD | -42916.839% |
| Blueprint Medicines Corporation | 774.12 Million USD | -87.766% |
| Organovo Holdings, Inc. | 1.39 Million USD | -104171.09% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| IO Biotech, Inc. | 2.49 Million USD | -58181.435% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| GT Biopharma, Inc. | 58 Thousand USD | -2506001.724% |
| Centessa Pharmaceuticals plc | 84.58 Million USD | -1618.375% |
| Hepion Pharmaceuticals, Inc. | 209.02 Thousand USD | -695306.66% |
| Cabaletta Bio, Inc. | 5.01 Million USD | -28866.501% |
| Summit Therapeutics Inc. | 106.09 Million USD | -1269.984% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 110.35 Million USD | -1217.112% |
| BioRestorative Therapies, Inc. | 162.31 Thousand USD | -895394.002% |
| Turnstone Biologics Corp. | 3.21 Million USD | -45125.233% |
| Pulmatrix, Inc. | 8.75 Million USD | -16500.491% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 247 Thousand USD | -588377.328% |
| Aurinia Pharmaceuticals Inc. | 97.6 Million USD | -1389.175% |
| Vigil Neuroscience, Inc. | 13.85 Million USD | -10394.866% |
| Intellia Therapeutics, Inc. | 115.34 Million USD | -1160.156% |
| Cytokinetics, Incorporated | 755.77 Million USD | -92.325% |
| Exelixis, Inc. | 189.94 Million USD | -665.246% |
| Nurix Therapeutics, Inc. | 30.61 Million USD | -4647.955% |
| Apellis Pharmaceuticals, Inc. | 110.92 Million USD | -1210.345% |
| Evogene Ltd. | 1.13 Million USD | -127627.504% |
| Replimune Group, Inc. | 75.86 Million USD | -1815.854% |
| PDS Biotechnology Corporation | 23.85 Million USD | -5994.09% |
| Hoth Therapeutics, Inc. | 55.16 Thousand USD | -2634793.501% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -52072.972% |
| ESSA Pharma Inc. | 80.32 Thousand USD | -1809404.78% |
| TNF Pharmaceuticals, Inc. | 48.87 Thousand USD | -2974197.115% |
| BioLineRx Ltd. | 11.59 Million USD | -12440.238% |
| Avid Bioservices, Inc. | 207.83 Million USD | -599.375% |
| Insmed Incorporated | 1.2 Billion USD | -20.726% |
| VistaGen Therapeutics, Inc. | 2.12 Million USD | -68463.16% |
| Zentalis Pharmaceuticals, Inc. | 45.77 Million USD | -3075.538% |
| Sagimet Biosciences Inc. | 65 Thousand USD | -2236113.846% |
| MediWound Ltd. | 6.71 Million USD | -21559.052% |
| MiMedx Group, Inc. | 48.09 Million USD | -2921.973% |
| OmniAb, Inc. | 25.56 Million USD | -5586.55% |
| Alector, Inc. | 38.91 Million USD | -3634.876% |
| Seres Therapeutics, Inc. | 213.93 Million USD | -579.427% |
| PTC Therapeutics, Inc. | 415.02 Million USD | -250.228% |
| Mereo BioPharma Group plc | 5.95 Million USD | -24321.018% |
| Zai Lab Limited | 15.15 Million USD | -9493.684% |
| Revance Therapeutics, Inc. | 478.43 Million USD | -203.812% |
| Syndax Pharmaceuticals, Inc. | 1.63 Million USD | -88801.468% |
| Aura Biosciences, Inc. | 19.55 Million USD | -7332.321% |
| Immunic, Inc. | 1.33 Million USD | -108860.945% |
| Dyne Therapeutics, Inc. | 27.41 Million USD | -5201.984% |
| Tarsus Pharmaceuticals, Inc. | 31.73 Million USD | -4480.673% |
| Veracyte, Inc. | 12.63 Million USD | -11408.622% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | -125.402% |
| FibroGen, Inc. | 170.45 Million USD | -752.741% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -15906.376% |
| Allakos Inc. | 41.46 Million USD | -3405.46% |
| scPharmaceuticals Inc. | 40.26 Million USD | -3509.573% |
| Fulcrum Therapeutics, Inc. | 10.82 Million USD | -13332.576% |
| Corcept Therapeutics Incorporated | 151 Thousand USD | -962508.609% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| NLS Pharmaceutics AG | 1.63 Million USD | -88869.705% |
| Sonnet BioTherapeutics Holdings, Inc. | 203.91 Thousand USD | -712730.107% |
| Amylyx Pharmaceuticals, Inc. | 4.23 Million USD | -34205.853% |
| Precigen, Inc. | 7.09 Million USD | -20381.034% |
| Fortrea Holdings Inc. | 1.67 Billion USD | 13.377% |
| KalVista Pharmaceuticals, Inc. | 7.31 Million USD | -19765.232% |
| Incyte Corporation | 38.28 Million USD | -3696.43% |
| Alzamend Neuro, Inc. | 300.71 Thousand USD | -483262.597% |
| Cara Therapeutics, Inc. | 43.16 Million USD | -3267.246% |
| XBiotech Inc. | - USD | -Infinity% |
| Aligos Therapeutics, Inc. | 11.13 Million USD | -12950.269% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -52072.972% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| CRISPR Therapeutics AG | 238.63 Million USD | -509.113% |
| Akero Therapeutics, Inc. | 26.04 Million USD | -5481.304% |
| Eliem Therapeutics, Inc. | 349 Thousand USD | -416386.819% |
| Lyra Therapeutics, Inc. | 26.88 Million USD | -5307.31% |
| Foghorn Therapeutics Inc. | 45.07 Million USD | -3124.855% |
| Agenus Inc. | 350.24 Million USD | -315.005% |
| Kiora Pharmaceuticals, Inc. | 106.89 Thousand USD | -1359732.914% |
| Y-mAbs Therapeutics, Inc. | 1.41 Million USD | -102334.038% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -3113.235% |
| Ultragenyx Pharmaceutical Inc. | 43.16 Million USD | -3267.09% |
| Metagenomi, Inc. Common Stock | 48.22 Million USD | -2913.828% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -886382.646% |
| BioCryst Pharmaceuticals, Inc. | 848.71 Million USD | -71.264% |
| UroGen Pharma Ltd. | 100.21 Million USD | -1350.435% |
| Gain Therapeutics, Inc. | 1.02 Million USD | -141377.694% |
| Sutro Biopharma, Inc. | 182.74 Million USD | -695.375% |
| Creative Medical Technology Holdings, Inc. | 14.19 Thousand USD | -10240417.12% |
| Lisata Therapeutics, Inc. | 305 Thousand USD | -476470.164% |
| Chemomab Therapeutics Ltd. | 392 Thousand USD | -370698.873% |
| Stoke Therapeutics, Inc. | 6.83 Million USD | -21166.116% |
| Chimerix, Inc. | 2.14 Million USD | -67695.662% |
| Reneo Pharmaceuticals, Inc. | 973 Thousand USD | -149287.359% |
| Outlook Therapeutics, Inc. | 35.55 Million USD | -3988.112% |
| 60 Degrees Pharmaceuticals, Inc. | 172.67 Thousand USD | -841687.077% |
| Pluri Inc. | 29.61 Million USD | -4808.615% |
| Cue Biopharma, Inc. | 14.69 Million USD | -9791.385% |
| MeiraGTx Holdings plc | 89.26 Million USD | -1528.36% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Cadrenal Therapeutics, Inc. Common Stock | 21.35 Thousand USD | -6808045.199% |
| Cidara Therapeutics, Inc. | 4.87 Million USD | -29703.957% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Scholar Rock Holding Corporation | 61.81 Million USD | -2251.32% |
| Sana Biotechnology, Inc. | 104.09 Million USD | -1296.345% |
| Elicio Therapeutics, Inc. | 6.91 Million USD | -20914.009% |
| NLS Pharmaceutics AG | 1.63 Million USD | -88869.705% |
| Adlai Nortye Ltd. American Depositary Shares | 31.54 Million USD | -4507.388% |
| Nutriband Inc. | 241.28 Thousand USD | -602315.815% |
| Protara Therapeutics, Inc. | 5.46 Million USD | -26487.507% |
| Vor Biopharma Inc. | 35.66 Million USD | -3976.105% |
| Roivant Sciences Ltd. | 499.74 Million USD | -190.854% |
| ProKidney Corp. | 4.41 Million USD | -32837.661% |
| Applied Therapeutics, Inc. | 1.22 Million USD | -118459.462% |
| Daré Bioscience, Inc. | 5.31 Million USD | -27231.692% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 16.455% |
| Titan Pharmaceuticals, Inc. | 565 Thousand USD | -257163.54% |
| Bicycle Therapeutics plc | 44.95 Million USD | -3133.248% |
| Tango Therapeutics, Inc. | 38.92 Million USD | -3634.684% |
| Galectin Therapeutics Inc. | 71.8 Million USD | -1924.23% |
| Revolution Medicines, Inc. Warrant | 87.94 Million USD | -1552.801% |
| Atai Life Sciences N.V. | 16.47 Million USD | -8722.16% |
| Renovaro Biosciences Inc. | 2.45 Million USD | -59204.014% |
| Aerovate Therapeutics, Inc. | 675 Thousand USD | -215239.111% |
| MediciNova, Inc. | 215.92 Thousand USD | -673065.344% |
| Praxis Precision Medicines, Inc. | 2.49 Million USD | -58158.076% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -115166.196% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Protagonist Therapeutics, Inc. | 1.14 Million USD | -127291.674% |
| Axsome Therapeutics, Inc. | 186.37 Million USD | -679.913% |
| Biomea Fusion, Inc. | 10.29 Million USD | -14017.512% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Erasca, Inc. | 55.85 Million USD | -2502.157% |
| Cullinan Oncology, Inc. | 3.59 Million USD | -40388.552% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -15766.598% |
| 4D Molecular Therapeutics, Inc. | 14.67 Million USD | -9807.566% |
| Kiniksa Pharmaceuticals, Ltd. | 12.25 Million USD | -11757.881% |
| bluebird bio, Inc. | 330.32 Million USD | -340.032% |
| Ventyx Biosciences, Inc. | 12.5 Million USD | -11522.733% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| Imunon, Inc. | 1.62 Million USD | -89364.3% |
| BioMarin Pharmaceutical Inc. | 1.13 Billion USD | -28.192% |
| BioAtla, Inc. | 2.46 Million USD | -58986.951% |
| Allogene Therapeutics, Inc. | 95.12 Million USD | -1428.095% |
| Larimar Therapeutics, Inc. | 5.54 Million USD | -26108.781% |
| DBV Technologies S.A. | 14.38 Million USD | -10007.357% |
| Fortress Biotech, Inc. | 88.59 Million USD | -1540.711% |
| Avidity Biosciences, Inc. | 9.85 Million USD | -14653.745% |
| Kezar Life Sciences, Inc. | 18.93 Million USD | -7577.278% |
| aTyr Pharma, Inc. | 15.09 Million USD | -9529.275% |
| Viridian Therapeutics, Inc. | 21.04 Million USD | -6805.83% |
| EyeGate Pharmaceuticals, Inc. | 326.49 Thousand USD | -445097.6% |
| Galecto, Inc. | 249 Thousand USD | -583650.602% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -88979.9% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 3.049% |
| Lexicon Pharmaceuticals, Inc. | 106.06 Million USD | -1270.436% |
| Entera Bio Ltd. | 390 Thousand USD | -372602.308% |
| Travere Therapeutics, Inc. | 404.78 Million USD | -259.09% |
| Sensei Biotherapeutics, Inc. | 6.2 Million USD | -23313.966% |
| Xencor, Inc. | 83.43 Million USD | -1642.142% |
| Orchestra BioMed Holdings, Inc. | 1.68 Million USD | -86061.174% |
| Spruce Biosciences, Inc. | 4.6 Million USD | -31436.971% |
| Coeptis Therapeutics Holdings, Inc. | 1.22 Million USD | -118631.264% |
| Vanda Pharmaceuticals Inc. | 9.4 Million USD | -15356.604% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -886382.646% |
| Portage Biotech Inc. | 47 Thousand USD | -3092536.17% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -115166.196% |
| Olema Pharmaceuticals, Inc. | 2.41 Million USD | -60038.146% |
| OncoCyte Corporation | 2.86 Million USD | -50563.611% |
| Processa Pharmaceuticals, Inc. | 150.55 Thousand USD | -965360.234% |
| Purple Biotech Ltd. | 351 Thousand USD | -414013.675% |
| CollPlant Biotechnologies Ltd. | 3.15 Million USD | -45912.631% |
| Onconetix, Inc. | 9.88 Million USD | -14603.343% |
| MacroGenics, Inc. | 33.97 Million USD | -4178.764% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Apogee Therapeutics, Inc. | 2.03 Million USD | -71362.13% |
| Neumora Therapeutics, Inc. Common Stock | 5.23 Million USD | -27687.02% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Prime Medicine, Inc. | 13.63 Million USD | -10561.916% |
| Aditxt, Inc. | 18.21 Million USD | -7878.593% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.73 Million USD | -5336.229% |
| Curis, Inc. | 2.79 Million USD | -51923.586% |
| Carmell Therapeutics Corporation | 2.13 Million USD | -67935.277% |
| Adagene Inc. | 22.3 Million USD | -6416.104% |
| Achieve Life Sciences, Inc. | 16.73 Million USD | -8587.699% |
| BeiGene, Ltd. | 930.18 Million USD | -56.263% |
| Inhibrx Biosciences, Inc. | 210.14 Million USD | -591.697% |
| GlycoMimetics, Inc. | 808.4 Thousand USD | -179703.984% |
| Maravai LifeSciences Holdings, Inc. | 610.96 Million USD | -137.908% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| SciSparc Ltd. | 76 Thousand USD | -1912451.316% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 2.5 Million USD | -57995.084% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -1672.245% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Arcutis Biotherapeutics, Inc. | 205.91 Million USD | -605.889% |
| Acrivon Therapeutics, Inc. Common Stock | 4.64 Million USD | -31199.289% |
| Alnylam Pharmaceuticals, Inc. | 2.68 Billion USD | 45.817% |
| ADMA Biologics, Inc. | 141.41 Million USD | -927.832% |
| Rigel Pharmaceuticals, Inc. | 60.57 Million USD | -2299.411% |
| Clene Inc. | 32.16 Million USD | -4419.57% |
| Celldex Therapeutics, Inc. | 2.54 Million USD | -57080.921% |
| Cogent Biosciences, Inc. | 18.85 Million USD | -7609.855% |
| Boundless Bio, Inc. Common Stock | 2.19 Million USD | -66120.456% |
| Recursion Pharmaceuticals, Inc. | 50.67 Million USD | -2768.525% |
| Adicet Bio, Inc. | 20.92 Million USD | -6846.755% |
| Contineum Therapeutics, Inc. Class A Common Stock | 193.19 Million USD | -652.381% |
| Absci Corporation | 15.95 Million USD | -9009.099% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 15.3 Million USD | -9398.392% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 20.29 Million USD | -7062.761% |
| Surrozen, Inc. | 3.37 Million USD | -42916.839% |
| Generation Bio Co. | 97.89 Million USD | -1384.809% |
| Astria Therapeutics, Inc. | 329 Thousand USD | -441705.167% |
| Caribou Biosciences, Inc. | 27.48 Million USD | -5188.481% |
| Black Diamond Therapeutics, Inc. | 25.29 Million USD | -5645.668% |
| Janux Therapeutics, Inc. | 24.54 Million USD | -5822.659% |
| Invivyd, Inc. | 2.16 Million USD | -67038.06% |
| Cingulate Inc. | 3.13 Million USD | -46263.416% |
| Relay Therapeutics, Inc. | 53.46 Million USD | -2618.623% |
| Quoin Pharmaceuticals, Ltd. | 3523.73 USD | -41249910.642% |
| Tenax Therapeutics, Inc. | 500.9 Thousand USD | -290083.728% |
| Spero Therapeutics, Inc. | 5.54 Million USD | -26122.966% |
| Jaguar Health, Inc. | 35.86 Million USD | -3953.371% |
| Artelo Biosciences, Inc. | 63 Thousand USD | -2307104.762% |
| 2seventy bio, Inc. | 256.67 Million USD | -466.3% |
| Clearside Biomedical, Inc. | 43 Million USD | -3280.245% |
| Terns Pharmaceuticals, Inc. | 603 Thousand USD | -240951.244% |
| ACADIA Pharmaceuticals Inc. | 57.2 Million USD | -2440.93% |
| Capricor Therapeutics, Inc. | 5.61 Million USD | -25799.842% |
| Citius Pharmaceuticals, Inc. | 481.24 Thousand USD | -301937.216% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 28.27 Million USD | -5041.267% |
| Innoviva, Inc. | 449.07 Million USD | -223.673% |
| Bolt Biotherapeutics, Inc. | 20.21 Million USD | -7088.976% |
| Entrada Therapeutics, Inc. | 68.23 Million USD | -2030.352% |
| ALX Oncology Holdings Inc. | 17.19 Million USD | -8352.282% |
| Vir Biotechnology, Inc. | 124.54 Million USD | -1067.126% |
| Evaxion Biotech A/S | 10.86 Million USD | -13272.419% |
| Ocular Therapeutix, Inc. | 83.38 Million USD | -1643.082% |
| Verve Therapeutics, Inc. | 74.9 Million USD | -1840.458% |
| Tyra Biosciences, Inc. | 6.49 Million USD | -22275.908% |
| Galmed Pharmaceuticals Ltd. | 41 Thousand USD | -3545117.073% |
| Unity Biotechnology, Inc. | 26.99 Million USD | -5285.472% |
| Connect Biopharma Holdings Limited | 465 Thousand USD | -312489.032% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| AlloVir, Inc. | 27.42 Million USD | -5199.278% |
| ORIC Pharmaceuticals, Inc. | 10.21 Million USD | -14132.243% |
| Catalyst Pharmaceuticals, Inc. | 3.55 Million USD | -40764.183% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -93375.177% |
| Viking Therapeutics, Inc. | 1.26 Million USD | -115260.238% |
| Keros Therapeutics, Inc. | 14.44 Million USD | -9963.272% |
| SELLAS Life Sciences Group, Inc. | 906 Thousand USD | -160334.768% |
| Crinetics Pharmaceuticals, Inc. | 51.72 Million USD | -2709.966% |
| ImmunityBio, Inc. | 883.67 Million USD | -64.488% |
| Korro Bio, Inc. | 33.2 Million USD | -4277.207% |
| C4 Therapeutics, Inc. | 70.97 Million USD | -1947.93% |
| Kineta, Inc. | 1.31 Million USD | -110267.426% |
| Lantern Pharma Inc. | 234.47 Thousand USD | -619822.72% |
| BioVie Inc. | 6.11 Million USD | -23683.876% |
| Codexis, Inc. | 22.36 Million USD | -6399.459% |
| Celularity Inc. | 65.41 Million USD | -2121.959% |
| Eledon Pharmaceuticals, Inc. | 383 Thousand USD | -379414.099% |
| Virax Biolabs Group Limited | 224.3 Thousand USD | -647933.437% |
| Kodiak Sciences Inc. | 181.63 Million USD | -700.266% |
| Cibus, Inc. | 24.62 Million USD | -5803.655% |
| Annexon, Inc. | 31.35 Million USD | -4535.749% |
| Assembly Biosciences, Inc. | 2.34 Million USD | -61964.005% |
| Moderna, Inc. | - USD | -Infinity% |
| Adverum Biotechnologies, Inc. | 75.03 Million USD | -1837.122% |
| Avalo Therapeutics, Inc. | 3.9 Million USD | -37141.583% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Eyenovia, Inc. | 16.1 Million USD | -8923.844% |
| Puma Biotechnology, Inc. | 111.49 Million USD | -1203.739% |
| Monte Rosa Therapeutics, Inc. | 46.03 Million USD | -3057.191% |
| Wave Life Sciences Ltd. | 32.11 Million USD | -4425.621% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -147467.411% |
| Xilio Therapeutics, Inc. | 11.45 Million USD | -12586.908% |
| Alkermes plc | 290.73 Million USD | -399.962% |
| Arcellx, Inc. | 97.62 Million USD | -1388.9% |
| Moolec Science SA | 2.64 Million USD | -54848.212% |
| Cardiff Oncology, Inc. | 2.14 Million USD | -67537.925% |
| LAVA Therapeutics N.V. | 6.31 Million USD | -22924.537% |
| Enanta Pharmaceuticals, Inc. | 26.51 Million USD | -5382.363% |
| Regulus Therapeutics Inc. | 3.1 Million USD | -46758.124% |
| Atea Pharmaceuticals, Inc. | 2.4 Million USD | -60413.697% |
| Compass Therapeutics, Inc. | 1.73 Million USD | -83774.149% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| Humacyte, Inc. | 58.1 Million USD | -2401.53% |
| Acumen Pharmaceuticals, Inc. | 28.48 Million USD | -5002.464% |
| Geron Corporation | 85.89 Million USD | -1592.149% |
| Verrica Pharmaceuticals Inc. | 45.51 Million USD | -3093.889% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Royalty Pharma plc | 6.13 Billion USD | 76.309% |
| TFF Pharmaceuticals, Inc. | 115.25 Thousand USD | -1261061.435% |
| Notable Labs, Ltd. | 2.04 Million USD | -70838.946% |
| Mersana Therapeutics, Inc. | 33.83 Million USD | -4196.598% |
| Structure Therapeutics Inc. | 5.45 Million USD | -26555.763% |
| IN8bio, Inc. | 4.89 Million USD | -29606.499% |
| 89bio, Inc. | 27.1 Million USD | -5262.03% |
| DiaMedica Therapeutics Inc. | 400 Thousand USD | -363284.75% |
| Vera Therapeutics, Inc. | 53.7 Million USD | -2606.373% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| Genelux Corporation | 2.51 Million USD | -57603.017% |
| Trevi Therapeutics, Inc. | 1.33 Million USD | -108535.202% |
| Liquidia Corporation | 3.5 Million USD | -41394.119% |
| Mustang Bio, Inc. | 2.49 Million USD | -58088.11% |
| Immunovant, Inc. | 138 Thousand USD | -1053189.13% |
| Vericel Corporation | 88.14 Million USD | -1549.069% |
| Quantum-Si incorporated | 15.3 Million USD | -9398.392% |
| Arbutus Biopharma Corporation | 8.72 Million USD | -16567.114% |
| XOMA Corporation | 124.45 Million USD | -1067.97% |
| ARS Pharmaceuticals, Inc. | 274 Thousand USD | -530388.686% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -1779453.134% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -10848.622% |
| Vaxcyte, Inc. | 29.22 Million USD | -4873.785% |
| Xenon Pharmaceuticals Inc. | 10.9 Million USD | -13231.551% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| NeuroBo Pharmaceuticals, Inc. | 203 Thousand USD | -715929.064% |
| Tempest Therapeutics, Inc. | 20.66 Million USD | -6935.182% |
| Sol-Gel Technologies Ltd. | 1.65 Million USD | -87833.394% |
| Rhythm Pharmaceuticals, Inc. | 1.26 Million USD | -115260.238% |
| Soleno Therapeutics, Inc. | 403 Thousand USD | -360579.653% |
| Enlivex Therapeutics Ltd. | 1.03 Million USD | -140746.802% |
| PepGen Inc. | 20.1 Million USD | -7130.098% |
| Moleculin Biotech, Inc. | 574 Thousand USD | -253129.791% |
| United Therapeutics Corporation | 700 Million USD | -107.648% |
| Solid Biosciences Inc. | 26.26 Million USD | -5434.129% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -147467.411% |
| Immuneering Corporation | 4.46 Million USD | -32468.953% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | 101 Thousand USD | -1439047.525% |
| Belite Bio, Inc | 886 Thousand USD | -163956.321% |
| Pharming Group N.V. | 171.54 Million USD | -747.322% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bionomics Limited | 239.61 Million USD | -506.607% |
| Pyxis Oncology, Inc. | 21.33 Million USD | -6714.209% |
| uniQure N.V. | 138.4 Million USD | -950.177% |
| Windtree Therapeutics, Inc. | 16.83 Million USD | -8536.595% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 85.42 Million USD | -1601.578% |
| Altimmune, Inc. | 671 Thousand USD | -216522.802% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -10848.622% |
| Peak Bio, Inc. | 10.72 Million USD | -13456.847% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -15906.376% |
| FibroBiologics, Inc. Common Stock | 1.74 Million USD | -83102.003% |
| Benitec Biopharma Inc. | 284 Thousand USD | -511709.507% |
| Zura Bio Limited | - USD | -Infinity% |
| Amicus Therapeutics, Inc. | 445.05 Million USD | -226.595% |
| Salarius Pharmaceuticals, Inc. | 289.64 Thousand USD | -501738.125% |
| Compugen Ltd. | 1.35 Million USD | -107489.859% |
| Elevai Labs, Inc. Common Stock | 210.48 Thousand USD | -690453.426% |
| argenx SE | 20 Million USD | -7167.695% |
| Zevra Therapeutics, Inc. | 42.76 Million USD | -3298.819% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -1619.046% |
| NKGen Biotech, Inc. Common Stock | 19.92 Million USD | -7196.516% |
| Madrigal Pharmaceuticals, Inc. | 117.19 Million USD | -1140.295% |
| PolyPid Ltd. | 11.77 Million USD | -12240.088% |
| Aileron Therapeutics, Inc. | 91.45 Million USD | -1489.297% |
| Plus Therapeutics, Inc. | 4.18 Million USD | -34665.343% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Dianthus Therapeutics, Inc. | 585 Thousand USD | -248368.205% |
| Instil Bio, Inc. | 86.05 Million USD | -1589.101% |
| Elevation Oncology, Inc. | 30.13 Million USD | -4723.104% |
| Immunome, Inc. | 1.65 Million USD | -87993.273% |
| Verona Pharma plc | 51.32 Million USD | -2731.809% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| enGene Holdings Inc. Warrants | 9.77 Million USD | -14765.402% |
| Shattuck Labs, Inc. | 4.2 Million USD | -34491.599% |
| LENZ Therapeutics, Inc. | 362 Thousand USD | -401430.11% |
| Design Therapeutics, Inc. | 3.05 Million USD | -47557.016% |
| Leap Therapeutics, Inc. | 262 Thousand USD | -554685.878% |
| Seelos Therapeutics, Inc. | 14.22 Million USD | -10116.046% |
| Achilles Therapeutics plc | 4.61 Million USD | -31395.97% |
| Fractyl Health, Inc. Common Stock | 373.72 Million USD | -288.937% |
| Rani Therapeutics Holdings, Inc. | 30.09 Million USD | -4729.194% |
| MoonLake Immunotherapeutics | 3.69 Million USD | -39207.509% |
| Beam Therapeutics Inc. | 173.17 Million USD | -739.357% |
| Moolec Science SA | 2.64 Million USD | -54848.212% |
| Longboard Pharmaceuticals, Inc. | 475 Thousand USD | -305908.211% |
| AEON Biopharma, Inc. | 278 Thousand USD | -522755.755% |
| Aadi Bioscience, Inc. | 7.02 Million USD | -20593.892% |
| Enliven Therapeutics, Inc. | 335 Thousand USD | -433792.239% |
| Iovance Biotherapeutics, Inc. | 75.86 Million USD | -1816.03% |
| Taysha Gene Therapies, Inc. | 61.1 Million USD | -2278.678% |
| Inovio Pharmaceuticals, Inc. | 30.2 Million USD | -4711.571% |
| Athira Pharma, Inc. | 1.58 Million USD | -91605.931% |
| HCW Biologics Inc. | 6.45 Million USD | -22429.281% |
| XOMA Corporation | 124.45 Million USD | -1067.97% |
| NeurAxis, Inc. | 224.26 Thousand USD | -648049.023% |
| Lumos Pharma, Inc. | 6.58 Million USD | -21973.485% |
| enGene Holdings Inc. Common Stock | 9.77 Million USD | -14765.402% |
| 180 Life Sciences Corp. | 1.32 Million USD | -110010.835% |
| Nektar Therapeutics | 230.4 Million USD | -530.874% |
| NKGen Biotech, Inc. Warrants | 19.92 Million USD | -7196.516% |
| Opiant Pharmaceuticals, Inc. | 17.08 Million USD | -8410.121% |
| Arvinas, Inc. | 3.4 Million USD | -42651.147% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -93375.177% |
| Palisade Bio, Inc. | 369 Thousand USD | -393813.008% |
| Nutriband Inc. | 241.28 Thousand USD | -602315.815% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -88979.9% |
| CG Oncology, Inc. Common stock | 826 Thousand USD | -175873.245% |
| Tourmaline Bio, Inc. | 415 Thousand USD | -350150.361% |
| Merus N.V. | 12.16 Million USD | -11851.48% |
| Omega Therapeutics, Inc. | 128.42 Million USD | -1031.793% |
| Neurogene Inc. | 16.25 Million USD | -8842.104% |
| Mirum Pharmaceuticals, Inc. | 308.14 Million USD | -371.711% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| CervoMed Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 28.54 Million USD | -4992.81% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Quince Therapeutics, Inc. | 13.81 Million USD | -10422.217% |
| Rezolute, Inc. | 2.22 Million USD | -65139.632% |
| Clene Inc. | 32.16 Million USD | -4419.57% |
| Indaptus Therapeutics, Inc. | 175.05 Thousand USD | -830242.239% |
| BeyondSpring Inc. | 3.99 Million USD | -36283.955% |
| Synlogic, Inc. | 17.27 Million USD | -8314.119% |
| Allarity Therapeutics, Inc. | 1.3 Million USD | -111710.692% |
| Phio Pharmaceuticals Corp. | 35 Thousand USD | -4152868.571% |
| Peak Bio, Inc. | 10.72 Million USD | -13456.847% |
| Werewolf Therapeutics, Inc. | 51.92 Million USD | -2699.413% |
| Krystal Biotech, Inc. | 8.09 Million USD | -17858.231% |
| Karyopharm Therapeutics Inc. | 177.01 Million USD | -721.134% |
| SpringWorks Therapeutics, Inc. | 7.05 Million USD | -20497.123% |
| Lipella Pharmaceuticals Inc. | 136.59 Thousand USD | -1064030.928% |
| MannKind Corporation | 382.37 Million USD | -280.13% |
| Ikena Oncology, Inc. | 10.73 Million USD | -13436.403% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 409 Thousand USD | -355288.509% |
| Gossamer Bio, Inc. | 212.46 Million USD | -584.134% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 174 Thousand USD | -835267.241% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -15766.598% |
| Legend Biotech Corporation | 328.67 Million USD | -342.246% |
| Mural Oncology plc | 15 Million USD | -9584.449% |
| Disc Medicine, Inc. | 2.1 Million USD | -69083.198% |
| Champions Oncology, Inc. | 7.43 Million USD | -19463.109% |
| REGENXBIO Inc. | 89.29 Million USD | -1527.886% |
| Ensysce Biosciences, Inc. | 854.69 Thousand USD | -169964.83% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 552.98 Thousand USD | -262754.668% |
| Edgewise Therapeutics, Inc. | 5.41 Million USD | -26747.784% |
| Vaxart, Inc. | 26.51 Million USD | -5382.157% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 15.65 Million USD | -9183.423% |
| Cellectis S.A. | 92.85 Million USD | -1465.42% |
| Longeveron Inc. | 2.04 Million USD | -71117.001% |
| Repare Therapeutics Inc. | 3.41 Million USD | -42525.777% |
| Sarepta Therapeutics, Inc. | 1.39 Billion USD | -4.061% |
| Inozyme Pharma, Inc. | 46.59 Million USD | -3019.718% |
| Revolution Medicines, Inc. | 87.94 Million USD | -1552.801% |
| Nymox Pharmaceutical Corporation | 173 Thousand USD | -840095.954% |
| Third Harmonic Bio, Inc. | 3.95 Million USD | -36670.529% |
| ArriVent BioPharma, Inc. Common Stock | 317 Thousand USD | -458429.653% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 175 Thousand USD | -830493.714% |
| Vertex Pharmaceuticals Incorporated | 808.4 Million USD | -79.804% |
| Denali Therapeutics Inc. | 52.24 Million USD | -2682.372% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 14.4 Million USD | -9990.193% |
| Corvus Pharmaceuticals, Inc. | 1.37 Million USD | -105688.865% |
| Cingulate Inc. | 3.13 Million USD | -46263.416% |
| Passage Bio, Inc. | 26.29 Million USD | -5428.025% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.66 Million USD | -21708.537% |
| Day One Biopharmaceuticals, Inc. | 408 Thousand USD | -356159.559% |
| Oramed Pharmaceuticals Inc. | 894 Thousand USD | -162488.255% |
| Scinai Immunotherapeutics Ltd. | 20.56 Million USD | -6969.398% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 2.45 Million USD | -59200.989% |
| Carisma Therapeutics, Inc. | 3.12 Million USD | -46443.036% |
| Unicycive Therapeutics, Inc. | 811 Thousand USD | -179127.99% |
| OmniAb, Inc. | 25.56 Million USD | -5586.55% |
| Anew Medical, Inc. | 1.6 Million USD | -90463.178% |
| Fennec Pharmaceuticals Inc. | 29.58 Million USD | -4813.449% |
| Lipocine Inc. | 17.16 Thousand USD | -8467446.312% |
| Lexeo Therapeutics, Inc. Common Stock | 11.63 Million USD | -12389.594% |
| Nautilus Biotechnology, Inc. | 34.62 Million USD | -4097.583% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -24506.814% |
| G1 Therapeutics, Inc. | 57.17 Million USD | -2442.352% |
| Bellerophon Therapeutics, Inc. | 203 Thousand USD | -715929.064% |
| Sage Therapeutics, Inc. | 5.16 Million USD | -28042.091% |
| Ocugen, Inc. | 6.94 Million USD | -20841.349% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -10187.628% |
| Q32 Bio Inc. | 1.31 Million USD | -110183.687% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -216200.446% |
| Alumis Inc. Common Stock | 32.58 Million USD | -4361.446% |
| Equillium, Inc. | 824 Thousand USD | -176300.364% |
| Kyverna Therapeutics, Inc. | 9.07 Million USD | -15909.902% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | 300.8 Thousand USD | -483114.763% |
| Dominari Holdings Inc. | 3.02 Million USD | -47903.269% |
| Edesa Biotech, Inc. | 94.48 Thousand USD | -1538248.133% |
| vTv Therapeutics Inc. | 529 Thousand USD | -274671.078% |
| Bio-Techne Corporation | 419.53 Million USD | -246.462% |
| Agios Pharmaceuticals, Inc. | 71.99 Million USD | -1918.916% |
| Harmony Biosciences Holdings, Inc. | 193.56 Million USD | -650.927% |
| Prelude Therapeutics Incorporated | 16.88 Million USD | -8506.934% |
| Candel Therapeutics, Inc. | 22.76 Million USD | -6285.814% |
| iTeos Therapeutics, Inc. | 6.05 Million USD | -23893.711% |
| Nkarta, Inc. | 88.33 Million USD | -1545.41% |
| BioCardia, Inc. | 1.31 Million USD | -110435.285% |
| Iterum Therapeutics plc | 19.5 Million USD | -7350.607% |